OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Modified Bushen Yiqi formula enhances antitumor immunity by reducing the chemotactic recruitment of M2-TAMs and PMN-MDSCs in Lewis lung cancer-bearing mice
Qing Kong, Huahe Zhu, Weiyi Gong, et al.
Journal of Ethnopharmacology (2023) Vol. 319, pp. 117183-117183
Closed Access | Times Cited: 7
Qing Kong, Huahe Zhu, Weiyi Gong, et al.
Journal of Ethnopharmacology (2023) Vol. 319, pp. 117183-117183
Closed Access | Times Cited: 7
Showing 7 citing articles:
Interactions and communications in lung tumor microenvironment: Chemo/radiotherapy resistance mechanisms and therapeutic targets
Feng Yuan, Ying Jiang, Lin Yang, et al.
Journal of drug targeting (2025), pp. 1-33
Closed Access | Times Cited: 1
Feng Yuan, Ying Jiang, Lin Yang, et al.
Journal of drug targeting (2025), pp. 1-33
Closed Access | Times Cited: 1
Targeted modulation of myeloid-derived suppressor cells in the tumor microenvironment: Implications for cancer therapy
Yafeng Qi, Liying Zhang, Y Q Liu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 180, pp. 117590-117590
Closed Access | Times Cited: 5
Yafeng Qi, Liying Zhang, Y Q Liu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 180, pp. 117590-117590
Closed Access | Times Cited: 5
Traditional Chinese medicine in lung cancer treatment
Zhichao Xi, Rongchen Dai, Yufei Ze, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
Zhichao Xi, Rongchen Dai, Yufei Ze, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
A pH transformable nanocarrier for gradual and precise delivery of a natural immunomodulator and chemotherapy agent to trigger tumor apoptosis
Qianwen Sun, Wei Chen, Qi Zhang, et al.
Chemical Engineering Journal (2024) Vol. 495, pp. 153209-153209
Closed Access | Times Cited: 2
Qianwen Sun, Wei Chen, Qi Zhang, et al.
Chemical Engineering Journal (2024) Vol. 495, pp. 153209-153209
Closed Access | Times Cited: 2
Evaluation of efficacy, safety and underlying mechanism on Traditional Chinese medicine as synergistic agents for cancer immunotherapy: A preclinical systematic review and meta-analysis
Jing Li, Shipeng Fan, Hongxia Li, et al.
Journal of Ethnopharmacology (2024) Vol. 338, pp. 119035-119035
Closed Access | Times Cited: 2
Jing Li, Shipeng Fan, Hongxia Li, et al.
Journal of Ethnopharmacology (2024) Vol. 338, pp. 119035-119035
Closed Access | Times Cited: 2
[Research Progress of Granulocytic Myeloid-derived Suppressor Cells
in Non-small Cell Lung Cancer].
Chaodan Yang, Rui Zhu, Yuting Zhang, et al.
PubMed (2024) Vol. 27, Iss. 1, pp. 65-72
Closed Access
Chaodan Yang, Rui Zhu, Yuting Zhang, et al.
PubMed (2024) Vol. 27, Iss. 1, pp. 65-72
Closed Access
Inhibition of non-small cell lung cancer metastasis by knocking down APE1 through regulating myeloid-derived suppressor cells-induced immune disorders
Zhenlong Zhang, Yu‐Chen Lin, Xiaojie Pan, et al.
Aging (2024) Vol. 16, Iss. 12, pp. 10435-10445
Open Access
Zhenlong Zhang, Yu‐Chen Lin, Xiaojie Pan, et al.
Aging (2024) Vol. 16, Iss. 12, pp. 10435-10445
Open Access
